BioXell Initiates Phase II Clinical Trial with BXL-628 in Benign Prostatic Hyperplasia
March 27, 2003 07:25 ET
|
BioXell SpA
MILAN, Italy, March 27, 2003 (PRIMEZONE) -- BioXell SpA, the Italian biopharmaceutical company, today announced that it has initiated recruitment for the Phase II trial of its novel lead compound,...
BioXell Appoints Alex Martin as Chief Business Officer
January 08, 2003 04:52 ET
|
BioXell SpA
MILAN, Italy, Jan. 8, 2003 (PRIMEZONE) -- BioXell SpA, the Italian biopharmaceutical company focused on immunology, today announced the appointment of Alex Martin as Chief Business Officer. Mr Martin...
BioXell Announces an Exclusive Collaboration with TaiGen
September 09, 2002 04:47 ET
|
BioXell SpA
MILAN, Italy, Sept. 9, 2002 (PRIMEZONE) -- BioXell SpA, the Italian biopharmaceutical company focused on immunology, today announced an exclusive joint collaboration agreement with TaiGen...
BioXell Listed by Tornado Insider as One of Europe's Top 100 Start-Ups
July 18, 2002 06:13 ET
|
BioXell SpA
MILAN, Italy, July 18, 2002 (PRIMEZONE) -- July 2002 BioXell S.p.A. was recently named in the second annual "Tornado Insider 100" list as one of Europe's top emerging private tech companies. BioXell,...
BioXell Appoints Dr. Bernd Seizinger to Board of Directors
July 02, 2002 07:20 ET
|
BioXell SpA
MILAN, Italy, July 2, 2002 (PRIMEZONE) -- BioXell SpA, the Italian biopharmaceutical company focused on immunology, today announced the appointment of Professor Bernd Seizinger to the Board of...
BioXell Announces the Discovery of a Receptor Implicated in the Development of Chronic Obstructive Pulmonary Disease
June 26, 2002 06:17 ET
|
BioXell SpA
MILAN, Italy, June 26, 2002 (PRIMEZONE) -- BioXell SpA today announced the publication of a study in the May issue of The American Journal of Respiratory and Critical Care Medicine on the...
BioXell Announces the Formation of its Scientific Advisory Board
June 06, 2002 06:23 ET
|
BioXell SpA
MILAN, Italy, June 6, 2002 (PRIMEZONE) -- BioXell SpA, the recently-formed Italian biopharmaceutical company focused on immunology, today announced the formation of its Scientific Advisory Board. The...
BioXell SpA: Vitamin D3 Analogue Arrests the Development of Autoimmune Diabetes
April 26, 2002 07:27 ET
|
BioXell SpA
MILANO, Italy, April 26, 2002 (PRIMEZONE) -- BioXell SpA announced today the publication of a study in the May issue of the journal Diabetes describing the ability of a synthetic analogue of the...
BioXell: New Immunology Company Launched; Roche Spin-Out Raises Euro 22 Million from International Investors
March 26, 2002 07:56 ET
|
BioXell SpA
MILAN, Italy, March 26, 2002 (PRIMEZONE) -- BioXell SpA announced its official launch today at a press conference in Milan. The firm combines extensive industry experience with a competitive edge in...